Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dl-amphetamine Sulfate
2. Amphetamine Sulphate
3. Phenaminum
4. 60-13-9
5. Amphamine Sulfate
6. Amphetamini Sulfas
7. Dl-phenamine Sulfate
8. Dl-amphetamine Sulphate
9. Amphetaminium Sulfuricum
10. Desoxynorephedrine Sulfate
11. (+-)-amphetamine Sulfate
12. Dl-amphetamine Hydrogen Sulfate
13. (+-)-phenisopropylamine Sulfate
14. Amfetamine Sulfate
15. Amphetamine Sulfate [usp]
16. Dl-1-phenyl-2-aminopropane Sulfate
17. (+-)-2-amino-1-phenylpropane Sulfate
18. (+-)-alpha-methylphenethylamine Sulfate (2:1)
19. 6dpv8nk46s
20. 1-phenylpropan-2-amine Sulfate (2:1)
21. Amphetamine Sulfate (usp)
22. Fenopromin Sulfate
23. Penamine (van)
24. Ccris 3644
25. 1-phenyl-2-aminopropane Sulfate
26. Cerm 1767
27. Razemisches Phenylaminopropansulfat
28. Dl-alpha-methylphenethylamine Sulfate
29. Einecs 200-457-8
30. Unii-6dpv8nk46s
31. Nsc 170999
32. Dl-amphetamine Sulfate Salt
33. Benzadrine
34. Alpha-methylphenethylamine Sulfate, (+-)-
35. Benzedrine (tn)
36. Evekeo (tn)
37. Evekeo Odt
38. Rac-amphetamine Sulphate
39. D-amphetamine Sulfate Salt
40. Schembl41204
41. Amphetamine Sulfate [mi]
42. Dtxsid4020082
43. Phenethylamine, Alpha-methyl-, Sulfate (2:1), (+-)-
44. Chebi:51063
45. Amfetamine Sulfate [mart.]
46. Amphetamine Sulfate [vandf]
47. Amfetamine Sulfate [who-dd]
48. Bis{1-phenylpropan-2-amine} Sulfate
49. Amfetamine Sulfate [ep Impurity]
50. Amfetamine Sulfate [ep Monograph]
51. Amphetamine Sulfate [orange Book]
52. .beta.-phenylisopyropylaminesulfate
53. Benzeneethanamine, Alpha-methyl-, Sulfate
54. Amphetamine Sulfate [usp Monograph]
55. Amfetamine Sulfate [incb:green List]
56. Delcobese Component Amphetamine Sulfate
57. D02074
58. (+/-)-2-amino-1-phenylpropane Sulfate
59. (+/-)-2-amino-1-phenylpropane Sulphate
60. Amphetamine Sulfate Component Of Delcobese
61. Q21270844
62. (+/-)-.alpha.-methylphenethylamine Sulfate (2:1)
63. (+/-)-.alpha.-methylphenethylamine Sulphate (2:1)
64. Benzeneethanamine, .alpha.-methyl-, Sulfate (2:1), (+/-)-
65. Benzeneethanamine, .alpha.-methyl-, Sulphate (2:1), (+/-)-
66. Dl-amphetamine Sulfate Salt Solution, Drug Standard, 1.0 Mg/ml In Methanol
67. 2-(tetrahydro-furan-2-yl)-n-(3-trifluoromethyl-phenyl)-succinamicacid
68. 156-31-0
1. Amfetamine
2. Mydrial
3. Desoxynorephedrine
4. L Amphetamine
Molecular Weight | 368.5 g/mol |
---|---|
Molecular Formula | C18H28N2O4S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 368.17697855 g/mol |
Monoisotopic Mass | 368.17697855 g/mol |
Topological Polar Surface Area | 135 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 166 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14783
Submission : 2000-03-17
Status : Active
Type : II
NDC Package Code : 49812-0058
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : CA |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15089
Submission : 2000-10-13
Status : Active
Type : II
NDC Package Code : 49812-0059
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-10
Pay. Date : 2013-04-03
DMF Number : 23583
Submission : 2010-03-04
Status : Active
Type : II
Available Reg Filing : CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-10
Pay. Date : 2013-04-03
DMF Number : 24048
Submission : 2010-07-08
Status : Active
Type : II
Available Reg Filing : CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-03-17
Pay. Date : 2013-03-11
DMF Number : 15385
Submission : 2001-04-18
Status : Active
Type : II
Certificate Number : R0-CEP 2020-076 - Rev 00
Issue Date : 2021-07-26
Type : Chemical
Substance Number : 2752
Status : Valid
NDC Package Code : 0406-4942
Start Marketing Date : 2013-11-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-08
Pay. Date : 2013-05-31
DMF Number : 15425
Submission : 2001-05-09
Status : Active
Type : II
NDC Package Code : 0406-1950
Start Marketing Date : 2013-04-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16567
Submission : 2003-04-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15606
Submission : 2001-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5378
Submission : 1984-02-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15603
Submission : 2001-08-28
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-10
Pay. Date : 2013-04-03
DMF Number : 24048
Submission : 2010-07-08
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-10
Pay. Date : 2013-04-03
DMF Number : 23583
Submission : 2010-03-04
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15089
Submission : 2000-10-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14783
Submission : 2000-03-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2314
Submission : 1974-08-08
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-18
Pay. Date : 2012-12-12
DMF Number : 15308
Submission : 2001-02-26
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-18
Pay. Date : 2012-12-12
DMF Number : 15307
Submission : 2001-02-26
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15340
Submission : 2001-02-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15338
Submission : 2001-02-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5378
Submission : 1984-02-09
Status : Inactive
Type : II
Certificate Number : R0-CEP 2021-478 - Rev 00
Status : Valid
Issue Date : 2023-06-15
Type : Chemical
Substance Number : 2752
Certificate Number : CEP 2019-097 - Rev 01
Status : Valid
Issue Date : 2025-01-03
Type : Chemical
Substance Number : 2752
Certificate Number : R0-CEP 2020-076 - Rev 00
Status : Valid
Issue Date : 2021-07-26
Type : Chemical
Substance Number : 2752
NDC Package Code : 49812-0059
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49812-0058
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1970
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1941
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1942
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1940
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61960-0210
Start Marketing Date : 2016-10-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61960-0200
Start Marketing Date : 2017-09-11
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65392-0114
Start Marketing Date : 2001-10-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-4942
Start Marketing Date : 2013-11-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the...
About the Company : Axyntis Group, founded in 2007, is France’s leading independent multi-site player in fine chemicals with a €90 million annual turnover. Axyntis has become a key producer of API...
About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...
About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...
About the Company : Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners tur...
About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...
About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...
About the Company : At Embio, technology is the foundation of our success, driving leadership in every product we manufacture. With 30+ years of expertise in bacterial, fungal, and Category 1 GMO biot...
About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...
About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Approval Date : 2002-01-18
Application Number : 76137
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2002-01-18
Application Number : 76137
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 15MG
Approval Date : 2002-01-18
Application Number : 76137
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : AMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 2020-07-14
Application Number : 213898
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : AMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Approval Date : 2020-07-14
Application Number : 213898
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 15MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Approval Date : 2017-10-31
Application Number : 205673
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2017-10-31
Application Number : 205673
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
Excipients by Applications
Global Sales Information
Market Place
Reply
19 Jul 2024
Reply
18 Apr 2024
Reply
30 May 2023
Reply
23 Sep 2022
Reply
30 Sep 2021
Reply
20 Aug 2021
Reply
17 Dec 2020
Reply
17 Aug 2018
Reply
20 Jun 2024
Patents & EXCLUSIVITIES
Patent Expiration Date : 2032-06-28
US Patent Number : 9265737
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204326
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-06-28
Patent Expiration Date : 2032-06-28
US Patent Number : 9265737
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204326
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-06-28
Patent Expiration Date : 2025-10-07
US Patent Number : 8632802
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215401
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-10-07
Patent Expiration Date : 2025-10-07
US Patent Number : 8591941
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215401
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-10-07
Patent Expiration Date : 2029-08-24
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
US Patent Number : 8846100
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22063
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-24
Patent Expiration Date : 2027-03-15
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
US Patent Number : 9675704
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210526
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-15
Patent Expiration Date : 2027-03-15
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
US Patent Number : 9675704
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210526
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-15
Patent Expiration Date : 2027-03-15
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
US Patent Number : 8747902
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208147
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-15
Exclusivity Code : NP
Exclusivity Expiration Date : 2025-03-22
Application Number : 215401
Product Number : 2
Exclusivity Details :
Exclusivity Code : NP
Exclusivity Expiration Date : 2025-03-22
Application Number : 215401
Product Number : 3
Exclusivity Details :
Exclusivity Code : NP
Exclusivity Expiration Date : 2025-03-22
Application Number : 215401
Product Number : 1
Exclusivity Details :
Exclusivity Code : NP
Exclusivity Expiration Date : 2025-03-22
Application Number : 215401
Product Number : 4
Exclusivity Details :
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
81
PharmaCompass offers a list of Amphetamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amphetamine manufacturer or Amphetamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amphetamine manufacturer or Amphetamine supplier.
PharmaCompass also assists you with knowing the Amphetamine API Price utilized in the formulation of products. Amphetamine API Price is not always fixed or binding as the Amphetamine Price is obtained through a variety of data sources. The Amphetamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Stimulan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Stimulan, including repackagers and relabelers. The FDA regulates Stimulan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Stimulan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Stimulan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Stimulan supplier is an individual or a company that provides Stimulan active pharmaceutical ingredient (API) or Stimulan finished formulations upon request. The Stimulan suppliers may include Stimulan API manufacturers, exporters, distributors and traders.
click here to find a list of Stimulan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Stimulan DMF (Drug Master File) is a document detailing the whole manufacturing process of Stimulan active pharmaceutical ingredient (API) in detail. Different forms of Stimulan DMFs exist exist since differing nations have different regulations, such as Stimulan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Stimulan DMF submitted to regulatory agencies in the US is known as a USDMF. Stimulan USDMF includes data on Stimulan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Stimulan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Stimulan suppliers with USDMF on PharmaCompass.
A Stimulan CEP of the European Pharmacopoeia monograph is often referred to as a Stimulan Certificate of Suitability (COS). The purpose of a Stimulan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Stimulan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Stimulan to their clients by showing that a Stimulan CEP has been issued for it. The manufacturer submits a Stimulan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Stimulan CEP holder for the record. Additionally, the data presented in the Stimulan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Stimulan DMF.
A Stimulan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Stimulan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Stimulan suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Stimulan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Stimulan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Stimulan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Stimulan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Stimulan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Stimulan suppliers with NDC on PharmaCompass.
Stimulan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Stimulan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Stimulan GMP manufacturer or Stimulan GMP API supplier for your needs.
A Stimulan CoA (Certificate of Analysis) is a formal document that attests to Stimulan's compliance with Stimulan specifications and serves as a tool for batch-level quality control.
Stimulan CoA mostly includes findings from lab analyses of a specific batch. For each Stimulan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Stimulan may be tested according to a variety of international standards, such as European Pharmacopoeia (Stimulan EP), Stimulan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Stimulan USP).